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Abstract 
In this research the accessibility and accessibility of essential drugs in private and public facilities have been 
surveyed in the Calabar Metropolis, Cross River State with solutions proffered on how to improve upon the 
accessibility and availability of these essential drugs by respondents via structured questionnaires. About 37 
(40.2%) of the respondents were of the opinion that drug suppliers should be paid on time to enable them extend 
credit facilities and also the cost of drugs should be reduced to make the drugs more affordable. 27 (29.3%) 
respondents called for the enforcement of relevant drug policies, avoid corruption which meant diversion of 
monies that should be used to purchase essential drugs for the populace and multiple prescriptions should be 
discouraged. About 20% of the respondents were of the opinion that there should be effective transportation and 
distribution of drug products so that stock outs will be avoided when the drugs are taken to places where they 
will be effectively utilized and the incidences of expired drugs will be minimized with less wastage. More so, 
about 15% of the respondent believed that health personnel should be trained in inventory management of drugs 
and public education on drug use should be enhanced. In addition, storage facilities of drugs should be improved 
and finally about 7% of the respondents believed that making pharmacists in charge of distribution and sales of 
drug will improve accessibility and availability. Furthermore, the research shows 16.19 % and 44.76 %; OB and 
GB overall drug availability in the public health facilities respectively and 64.76 % and 82.3 0 %, OB and GB 
overall drug availability in the private health facilities indicating a higher drug availability in the private facilities. 
In facilities, Salbutamol inhaler 0.1mg dose and Glibenclamide 5mg tablets are the most readily accessible and 
available drugs.  
Keywords: Improving, availability, accessibility, essential drugs.  
 
1. Introduction 
According to WHO, (1995) health is defined a state of complete physical, social and mental wellbeing and not 
merely the absence disease or infirmity. Good health is one of the fundamental human rights and a basis for the 
development of individuals and nations. These developments cut across personal, social and economic 
development. To achieve these, essential drugs must be provided as well as ensuring access to basic health 
services. Generally one third of the world’s population lacks access to essential medicine and in countries like 
Africa and Asia; up to 50% of the total population do not even have the most basic essential drugs. Access is 
defined as the timely use of services according to needs (Peters et al.., 2008). 
According to Essien, (2005), about 50 million people die yearly whereby 20% of these are due to 
treatable communicable diseases such as diarrhea, malaria and tuberculosis. In developing countries this scenario 
is made worse by extreme poverty and deprivation, emergence of new diseases and high prices of newly 
developed essential drugs. There exist social gaps between the standards of health care between developed 
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nations of the world, According to the United Nation Development Programme Report (UNICEF, 1991) the 
likelihood of a child born in developing countries in Asia, Africa or Latin America dying before 5 years is 
roughly 10 times that of a child in Europe or Northern America. There exist social gaps between the standards of 
health care between developed nations of the world and the rest of the world.. In Nigeria the average life 
expectancy is 57.11years as compared to Kenya with 61.08 years and in USA of about 78.74 years (World Bank, 
2014).This shows that there is great disparity and inequality in health between nations. 
Drugs possess unique properties in the provision of health as they are an important component of the 
tools for health care practitioners the world over and are used at every level of the health care.  This situation 
made WHO to embark on a global essential drug initiative to promote and support practical and relevant policies 
to reduce avoidable social impacts in health and health care (WHO, 1996). 
Essential drugs initiative emerged from the growing gap between the potential of drugs to cure diseases 
and the limited ability of health system of poor countries to meet the need. At all levels of the health system of 
poor countries was the lack of modern drugs in sufficient quantities (Reich,1987).This initiative implies that 
developing countries despite limited resources can extend the accessibility and availability of the most needed 
drug to a wide spread  population  with a select list of essential or basic drugs (Essien, 2005). 
The essential drugs programme (EDP) and the Bamako Initiative (BI) was adopted as a means of 
actualizing this concept. WHO/UNICEF declared in Alma Ata that provision of essential drugs and vaccines to 
be one of the basic components of primary health care delivery and form an important tool for health care 
practitioners to achieve health care goals for their patients. The regular supply of certain drugs is used as 
indicators to evaluate progress  of any health care initiative.The concept of essential drugs and its 
implementation is flexible and adaptable to suit different situation and the choice of essential medicines remain a 
national responsibility (WHO, 1988). 
Drugs are a key component of any health system serving multiple social needs and occupying a unique 
position in Health Care Delivery (HCD). Availability and access still remain a problem to patients with out of 
stock syndrome in public/private health facilities (Essien, 2005). Drugs improve quality and quantity of life and 
improve health and drugs not being available in detrimental to the attainment of health. Shortages of drugs 
adversely affect the credibility of a health care system by reducing morale of health care workers. They provide 
cost effective way with benefits for the prevention of diseases, treatment of further ailments. Even though 
availability of appropriate drugs only is not sufficient to ensure the efficiency of a health system without efficient 
distribution prescription, pricing and rational use of medicines (Reich, 1987).) 
According to WHO, (1998)countries with high income pay for drugs through government insurance and 
social programmers while in developing countries 50 – 90% of the cost of drugs is paid for by the patient. This 
represents the largest out of pocket household expense. According to WHO many people still lack access to 
essential drugs even through the concept that a restricted list of well-chosen medicine would meet the needs of 
most of the world in as valid as ever. 
Evolution of Health Care in Nigeria have been characterized by short term planning into development 
plans from the colonial era to the latest which was the 5 year strategic plan from 2004-2008 .There has been 
inability on the part of government to finance and improve health services due to corruption, bad governance, 
unstable economy, high population growth and cost of health care. The resultant effect of these is the 
unavailability of basic drugs giving rise to out of stock syndrome in public hospitals. In the private sector the 
drugs may be available and not accessible due to the high cost of the drugs. 
Drugs are not only used to cure diseases but serve multiple social, psychological and political functions 
and the key component of any health system. Appropriate drugs are a necessary element of a health system and 
there is no quality health care without appropriate drugs. Drugs includes any substance or mixture  of substances 
manufactured sold or advertised for use in the diagnosis, treatment ,mitigation or prevention of any diseases 
disorder or abnormal physical state or the symptoms thereof in man or animals ;restoring correcting or 
modifying organic functions in man or in animals, disinfection or the control of vermin , 
Drugs are used to prevent diseases through vaccines, in treatment and avoiding the progression of other 
illness, furthermore shortages of drugs reduce the morale of the health workers and the credibility of the health 
system. During the financial crisis in the late 1980’s essential drugs concept was encouraged due health 
ministries to search for ways to reduce drug cost and the basis was that a limited range of medicines would make 
healthcare better, drugs will be managed more effectively and scarce financial resources would be more 
efficiently utilized .There was also to be better access to health and drug needs (Quick, 2003). Prior to 1977 
before the essential drugs concept, national drug policies were not known with only a few countries having drug 
lists, with informal drug selection practices and unbiased drug information limited. Education about generic 
substitution and rational prescribing was not available and no ethical or drug promotional activities were limited 
and only in the industrialized countries were standards for good manufacturing practices (GMP) developed .But 
after about 25 years of essential drugsover 100 countries have national drug policies and more countries 
introduced essential drugs concept into curricula for medical and pharmacy students. 
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In recognition of the myriad of problems facing the developing countries concerning access to drugs, 
WHO and UNICEF in affiliation with UN member states, pharmaceutical companies globally and other donor 
agencies brought the essential drugs programme in 1975. 
 
1.1 The concept of essential drugs  
This concept of essential drugs emerged from the limited capability of poor countries to afford potential drugs to 
control basic diseases. The WHO defined essential drugs as “those concluded to be of the upmost importance 
and hence basic, indispensable and necessary for health need of the population. They should be available at all 
times in the proper dosage form to all the segments of the society. Poor countries lack modern drugs in sufficient 
quantities at all levels of the health care due to a myriad of problems some of which are:- 
1) Limited resources 
2) Problems arising from interactions of the pharmaceutical companies with social organization of poor 
countries due to product dumping, misleading achievements and product promotions and gift giving to 
Physicians and Pharmacists. 
3) Lack of government policy on procurement, distribution and prescription 
4) Poor training of Physicians and Pharmacists on relevant policies on procurement and rational drug use. 
The concept of essential drugs was a single solution to multiple problems and promised to extend access, reduce 
cost and improve treatment (Reich, 1987) 
 
1.2 Evolution of Essential Drug Concept 
In 1975, WHO’s Director General, Halfdan Mahler gave a report on the World Health Assembly that gave 
National Drug Policies (NDP) as a top priority for developing countries to meet their health needs and economic 
priorities. The request stressed the essential drug approach as an effective means to this. During the 28th World 
Health Assembly requested the WHO to help number states by activity on the selection and procurement at 
reasonable cost of essential drugs of established quality corresponding to the national health needs? A working 
document was prepared that described how lists of drugs are used, defined terms related to basic or essential 
drugs and drug policy, economics and evaluation, proposed criteria for drugs selection and provided a 
preliminary list of drugs. It also stressed the need for additional information to prescribers and patients. The 
model list was included for adaptation by each country and guidelines on the process of prescribing essential 
drug. 
In 1977, WHO prepared and published a model list of essential drugs which included 200 drugs and 
vaccines by generic name. Most products on the list were known to be therapeutically active and no longer under 
patent.In 1978, in the declaration of Alma Ata, provision of essential drugs and vaccines was one of the basic 
components of primary healthcare. In 1981, an action program on Essential drugs and vaccines was established 
and Health Action International(HAI)as a network of consumer and public interest organization to promote safe, 
rationale and economic use of pharmaceuticals worldwide to promote full implementation of WHO essential 
drugs program and to seek non-drug solution to health and nutrition problem.By 1990, more than 100 countries 
mostly developing countries including Nigeria had and were using their own list of essential drugs and WHO has 
made several revisions and the 15th revision was released in 2007 (WHO, 2009). 
 
1.3 Essential Drugs: Social and Potential Impact 
Though the concept of essential drugs emerged from the WHO, it also was reflected in social and political 
process globally that was related to poor countries, multinationals enterprises and consumer organizations. 
(Reich 1987).  Favorable condition for the concept was due to the worldwide environment in the late 1970s and 
1980s and WHO staff and support organizations. 
The number of people estimated to have regular access to essential drugs has risen from 2.1 billion to 
about 4 billion in 2003 but at least one third of the world’s population still lack regular access to essential drugs. 
This lack of access mainly affects the poor population .According to Peters et al., 2008 people in poor countries 
have less access to health services when compared to developed countries and even within countries the poor 
have access to less health services which also includes access to quality essential drugs. There is a causal 
relationship to poverty because health care that is delayed or unavailable worsens health leading to lost income 
and higher health costs which contributes to poverty. 
Access is related to timely use of service according to need and dimensions of access are; 
• Geographical Access  meaning the physical distance the user has to travel to the delivery point 
• Availability i.e. having the right type of drugs for those in need as well as the appropriate type of 
personnel to provide the service. 
• Financial accessibility i.e. the relationship between the price of service offered and the willingness and 
ability of the user to pay for the drugs 
• Acceptability i.e. the responsiveness of the pharmacist to the social and cultural dynamics of the 
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individuals and communities using the drugs. 
The concept of essential drugs is supposed to be adaptable and flexible depending on different scenario 
whereby choice of essential drugs differs from country to country. There is not one size fits all.Issues also 
associated with inaccessibility of drugs are counterfeit and substandard drugs. Products must be produced 
according to Good Manufacturing Practices (GMP) but in developing countries technical, financial and human 
resources required to do this are lacking. This leads to decrease in effectiveness and safety especially for poor 
populations who are attracted by lower priced drugs (Pe’coul et al.,1999).Financial access does not translate into 
correct use as there is need for continuous training of health personnel ,improved of drugs management and 
provision of correct and reliable pharmacological information. 
 
1.4 Bamako Initiative 
This initiative was initiated by UNICEF in collaboration with WHO in 1987 and was inaugurated in Bamako, 
Mali .This was a means of enhancing health care delivery in Sub Saharan  Africa (Essien, 2005).During the 
meeting of the African Health Ministers ,the underutilization of public health facilities and the non-availability  
of essential drugs was discussed and the decisions taken that communities be allowed to manage health facilities 
on their own and charge a minimal fee for drugs .The basis for the Bamako Initiative(BI) was the difficulty in 
implementing Primary Health Care (PHC) services as proposed at the Alma Ata Convention by West African 
states .(Ridell, 2011).BI was seen as an African initiative to refocus and strengthen PHC with emphasis on 
maternal and child health ,cost recovery of initial supply of seed stock of essential drugs at the entry point.In the 
BI programme ,health care delivery is decentralized and sale of drugs is to raise money to buy new drugs and 
contribute to community development activities  making it a drug revolving fund (DRF).About 30 years after the 
BI ,the poor do not have access even though use of generic drugs has lowered costs for those who pay but not for 
those who cannot and the explanation was that BI was poorly interpreted and implemented (Ridell, 2011). In the 
later review by member countries it was reported that an improvement in the management of drugs at different 
levels and successful participation of private sector seen .Evidence shows that health system have been 
strengthened and political will is necessary in the successful implementation of the Bamako Initiative. (WHO, 
1999) 
 
1.5 Access to Medicines 
Access to health services of which drugs  form  an integral part is related to the timely use of services according 
to need .There is distinction between the supply of and the opportunity of these services and the actual 
realization of the need .(Peters et al., 2008).Barriers to access can be either from the supply or demand. 
Constraints to demand will be influenced by individuals, household or communities ability to use these services 
while supplybarriers include situations in health services that may hinder the provision of services (Ensor and 
Cooper, 2004). 
1.5.1  Dimension of Access to Medicines 
A) Geographical Accessibility; The physical distance and travel time from service delivery point to the 
user .An inverse relationship exists between distance or the time it takes to travel from service delivery 
point to the user and the use of these services including access to essential drugs. Good roads are 
required for people to get health facilities and also affects the availability of drugs as they are necessary 
for easy distribution of drugs and medical consumables. 
B) Financial Accessibility; Affordability and the financing mechanisms for the poor and underprivileged 
have been a major determinant of access to health services and medicines. In low income countries like 
Nigeria, end users pay for the bulk of their medicines  from household expenses and national health 
policies are not as widely applicable as in developed countries .The reasons end users pay for their 
medicines are because of government inability to adequately fund the health system ,low wages and 
salaries and the scarcity of key medical supplies such as medicines .(Peters et al., 2008).Price and 
affordability determines access to a very great extent and poverty deters the poor from seeking 
treatment .Apart from the direct costs of themedicines ,indirect costs also exists which includes 
transportation cost ,time wasted ,food and lodging expenses. The results of these is that there is 
catastrophic spending which is spending of a high proportion of household finances or distress 
financing –borrowing money or selling of assets resulting in deeper poverty and long term debt. 
C) Acceptability ; This can determine the utilization of such health services even though Declaration of 
Alma Ata proposed the need for primary healthcare  to be in line with prevailing cultural norms (Peters 
et al. ,2008). Patients consult different types of health providers from orthodox medical to traditional 
healers even patent medicine dealers and studies have shown that measurement of acceptability is 
variable and dependent on local situation. 
D) Availability; This is the opportunity of assessing the health care need including dugs as and when 
needed. Out of stock syndrome in public hospitals is a common feature in many parts of the developing 
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world .(Peters et al.,2008).According to Chandani et al., (2012),supply chain factors affect drug 
availability and that at lower levels of the health care like the PHCs ,fewer medicines were available 
than at the general hospitals and Teaching Hospitals. Frost and Reid, (2010) proposed the framework of 
availability being a function of supply chain and is linked to manufacturing, forecasting, procurement, 
distribution and delivery activities. 
 
1.6 Statement of the problem  
Access to essential drugs is key to the performance of the health care delivery system .The priority of health and 
drug policy should be to provide safe,effective and affordable essential drugs of good quality in the right 
quantity to the whole population especially the poor (Quick, 2003).Access is defined as having drugs 
continuously available at public or private health facilities that are within one hours walk of the 
population.(WHO, 1999b).The availability of drugs is one of the most visible signs that patients are receiving 
quality care .According to Uzochukwu et al., 2002, patients visits in Nigeria dropped by 50-75% when health 
facilities ran out of commonly used drugs. In Uganda the reason for the formal health services being inadequate 
was due to understaffing and irregular supply of essential drugs .From the perspective of policy makers and 
health providers, regular availability of drugs is a basic component necessary for an efficient health functioning 
system .In Cameroon studies have shown that regular supply, recovery of costs of purchase and better motivated 
staff improved the health system efficiency (Audebert and Mathonat, 2000). 
Cross River State was one of the initial states that adopted the Essential Drugs Programme in 1989.This 
was a step taken to ensure the availability of drugs and the seed stock was from the World Bank and the drugs 
were for treatment of common ailments . The expectation was that there should be rational selection, 
procurement and distribution methods of essential drugs so that cheap and good quality drugs be available and 
accessible to the people. The program could not be sustained. According to Erhun et al., (2001), branded 
prescription is still being practiced in many public institutions and this continues to partially erode the expected 
gains of the essential drug programme. In 1996, the Petroleum Special Trust Fund was initiated to run alongside 
the DRF in public hospitals which encouraged local manufacturers to produce drugs directly on a contract basis. 
The scheme was later phased out in 1999 and the situation is that out of stock syndrome and empty shelves are 
the norm. The justification for this study is to find out the reasons for this as the populace is forced to patronize 
private pharmacies and patent medicine dealers and ways of improving the essential drug accessibility and 
availability. 
 
1.7 Significance of the Study 
With the advent of the first Essential Drug List in 1977 and the Declaration of the Alma Ata in 1978that made 
provisions of essential drugs an element of primary health care,the understanding that more people will have 
regular access to essential drugs. According to Quick, (2003) the number of people with access worldwide to 
essential drugs have risen from 2.1 billion in 1977 to about 4 billion but one third of the population still lack 
regular access to essential medicines . WHO in 1988 has classified  Nigeria as a country with low health 
coverage of less than 30%  of the population and had experienced difficulties in Logistics ,Management and 
manpower of essential drugs Cross River State  is no exception .The result of this is that despite enacting laws 
and establishing essential drugs programs, the availability and accessibility of essential drugs in public health 
facilities have remained poor but in private pharmacies ,the availability is high but with relatively high prices. 
This study aims to confirm or dispute these facts by accessing the level of availability of some indicator essential 
drugs in public and private drug outlets, factors responsible for this and obtain recommendation from 
pharmacists on how to improve access and availability. 
 
1.8 Objectives of the Study 
There is a general objective and specific objectives. The general objective of the study is to find out the ways of 
improving on the accessibility and availability of essential drugs in Cross River State. 
The specific objectives are as follow: 
1. The level availability of essential drugs in public and  private health facilities 
2. The factors that improve on the availability and accessibility of the essential drugs 
3. The affordability of treatment of some acute and chronic disease conditions when compared to the daily 
minimum wage of a civil servant 
 
1.9 Research Questions 
Research questions were used to achieve these   specific objectives mentioned above: 
1. What is the level of availability and accessibility of the WHO indicator essential drugs in the public and 
private drug outlets? 
2. How can the availability and accessibility of these essential drugs be improved upon? 
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2. Research Methodology 
2.1 Study Setting 
Cross River State is one of the states in the South-South Geopolitical zone in Nigeria with Calabar as its state 
capital. It is located at the southernmost part of the country and has boundaries with Akwa Ibom State to the west, 
north by Benue and Ebonyi States while it has international borders with Cameroon, Equatorial Guinea and the 
Atlantic Ocean. The state comprises of 18 local government areas with a total population of 2,817,626 with 
1,459,530 males and 1,358,096females according to the 1991 population census.(Essien, 2005).There are a total 
of 402 health care facilities with a tertiary hospital ,state owned general hospitals and primary health care centres 
with several private owned pharmacy shops and drug outlets. There is a central EDP store that caters to all the 
health care centres in the state. Calabar South and Calabar municipality were chosen as representative local 
Government areas from the eighteen in the state. 
 
2.2 Study Design 
The study used a cross sectional descriptive study design usedto examine the factors that affect the essential 
drugs accessibility and availability. The descriptive study was considered to be appropriate because it provided 
reliable information and gave adequate description of a situation and not make generalization beyond the 
obvious.(Essien, 2005).The level of accessibility of essential drugs was based on the protocol developed by 
HAI/WHO (2009). To standardize the methodology, specific dosage forms and strength of each medicine 
surveyed was included. Medicines selected were based on HAI/WHO core list of 14 globally accepted medicines 
with additional 7 medicines based on local relevance used to treat a range of chronic and acute conditions. For 
each of the medicines, price data was collected on originator and the lowest priced generic at each facility. 
Structured questionnaires were administered to hospital pharmacists and superintendent pharmacists of 
consenting private pharmacies to investigate the factors that affect the accessibility and availability of essential 
drugs in the state. 
 
2.3 Population/Sample Characteristics 
The study population is made up of registered pharmacists of both public and private sector working in Calabar 
Municipality and Calabar South local Government .The population is finite and made up of both male and 
female. 
 
2.4 Inclusion Criteria 
Consenting pharmacists working in the public and private sectors. 
 
2.5 Size of the Sample 
The size of the sample was determined from the list of registered pharmacists in Calabar obtained from the 
Association of Hospital & Administrative Pharmacists of Nigeria , and Association of Community Pharmacists 
of Nigeria, Calabar Branch. 
 
2.6 Data Collection Instrument 
Data was collected using researcher administered structured questionnaire (Appendix 1) and sighting of the 
drugs .Two intern pharmacists were trained in collecting data from the pharmacy shops while the researcher 
carried out the data collection in the hospital. The questionnaire was pre –tested in Akpabuyo Local Government 
area to validate and corrections made before the final distribution and collection. 
 
2.7 Data Analysis 
The availability of individual medicines was calculated as percentage (%) of the health facilities where the 
medicines were found both for originator brands and generic brands .The accessibility was calculated in terms of 
affordability and as the cost of treatment of 30 days for chronic conditions and a full course of therapy for acute 
conditions when compared to the daily minimum wage of a government worker of N600.00 (Naira) per day .The 
price of medicines used was the median price of the lowest priced generic. Pretested questionnaires were also 
administered on hospital pharmacists and consenting superintendent pharmacists of private pharmacies.Data 
obtained was analyzed using Statistical package for Social Sciences (SPSS) for descriptive studies and presented 
in frequency tables and bar charts. 
 
2.8 Ethical Approval 
Ethical approval was sought and gotten from The Cross River State Health Research Ethics Committee (CRS-
HREC) with REC.NO.RP/REC/2015/295. Informed written consent was obtained from all respondents before 
administering questionnaires to them. 
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3.0 Results 
3.1 Sociodemographic Data 
Table 1. Age distribution of respondents 
 Frequency (%) 
21 – 30 38 (41.3) 
31 – 40 47 (51.1) 
41 – 50       7 (7.6)  
Total        92 (100.0) 
 
Table 2. Sex distribution of the respondents 
 Private Public  Total  
Female  5 (5.4%) 26(28.2%) 31 (33.7%) 
Male  27(29.3%) 34(37.0 %) 61(66.3%) 
Total  32 (34.8%) 60 (65.2%) 92(100.0%) 
p>0.05 (NS) 
 
Table 3. Educational qualification of respondents 
 Frequency (%) 
B.Pharm 82(89.2) 
FPCP 4(4.3) 
M. SC 4 (4..3) 
Ph.D. 2 (2.2) 
Total  92 (100.0) 
     Tables 1-3 show the demographic characteristics of the respondents. The respondents who were 
pharmacists were 92 in number with 61(66.3%) males and 31(33.7%) females. Most of them were between the 
ages of 31-40 years. About 82 (89.2%) had B. Pharm only as the least professional qualification with 4 (4.3%) 
being fellows,4(4.3%) with M.Sc. and 2(2.2%) with PhD with 32(3.8%) working in private pharmacy shops 
while 60(65.2%) worked in the public sector being hospital pharmacists. 
 
3.2 Characteristics of health facility 
Table 4. Type of health facility of the respondents 
 Private Public  Total  
Primary  0 (0.0%) 0 (0.0%) 0 (0.0%) 
Secondary   0 (0.0%) 10(10.9%) 10(10.9%) 
Tertiary  0 (0.0%) 50(54.3%) 50(54.3%) 
Pharmacy  
Total             
32 (34.8%) 
32(34.8%) 
0(00.0%) 
60(65.2%) 
32(34.8%) 
92(100.0%) 
Chi cal. = 12.000; df = 1; p<0.05 
     Table 4 shows the level of practice of the respondents with majority of them in the tertiary 
institutions being 50 (54.3%), 10(10.9%) in secondary institutions   while the community pharmacists that 
consented to be interviewed were 32 (34.8%).  
Table 5. Availability of essential medicines list in the health facilities 
 Private Public  
Available 16 (50.0%) 60(100.0%) 
Not available  16 (50.0%) 0 (0.0%) 
p>0.05 (NS) 
 
Table 6.  Services provided in the health facility of the respondents 
 Private Public  Total  
Out-patient care only 32 (100.0%) 0 (0.0%) 32 (100.0%) 
Out-patient and in-patient care   0 (0.0%) 60 (100.0%) 60 (100.0%) 
Maternal and child health  0 (0.0%) 60 (100.0%) 60 (100.0%) 
Medical cases only 0 (0.0%)  (00.0%) 0 (0.00%) 
Medical and surgical care 0 (0.0%) 60 (100.0%) 60(100.0%) 
Chi cal. = 12.000; df = 1; p<0.05 
      Table 6 shows the services provided by the health facility with all the private pharmacies providing 
only outpatient care while the public health facilities provided outpatient, in patient, maternal and child care, 
medical and surgical care. 
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Table 7. Availability of an alternative power supply in health facilities 
 Private Public  
Available 32 (100.0%) 60(100.0%) 
Not available  0 (0.0%) 0 (0.0%) 
p>0.05 (NS) 
 
Table 8: Availability of a good means of transportation in health facilities 
 Private Public 
Available 11 (34.3%) 40 (66.7%) 
Not available  21 (65.7%) 20 (33.3%) 
p>0.05 (NS) 
 
3.3 Awareness of essential drugs and goals 
Table 9. Awareness of the concept of essential drugs by the respondents 
 Private Public  
Aware 32(100.0%) 60 (100.0%) 
Not aware 0 (0.0%) 0 (0.0%) 
p>0.05 (NS) 
 
Table 10. Achievement of the goals of essential drugs 
 Private Public  
Achieved 11 (34.4%) 18 (33.3%) 
Not achieved 21 (65.6%) 42(66.7%) 
p>0.05 (NS). 
      Table 9 shows that all the respondents were aware of the concepts but differed in their opinion as to 
the attainment of the goals of essential drugs as shown in Table 10. But majority of the pharmacists both in the 
private sector and public sector (more than 65.0%) said the goals had not been achieved. 
Table 11. Sources of drugs in the health facility of respondents 
 Private Public  
Central medical stores  0 (0.0%) 20 (33.3%) 
Drug manufacturing companies   27 (84.4%) 40(66.7%) 
Open market  5 (15 .6%) 0 (0.0%) 
Donation  0 (0.0%) 0 (0.0%) 
p>0.05 (NS) 
      For the public or government owned pharmacies, 40(66.7%) dispensed drugs obtained from their 
central medical stores while the rest obtained drugs directly from drug manufacturing companies.  
 
3.4 Strategies on improving accessibility and availability of essential drugs in Calabar, Cross River State 
Table 16. Strategies on improving accessibility and availability of essential drugs in the state 
 Frequency   
(%) 
Improve on funding 55 (59.3) 
Payment of suppliers 37 (40.2) 
Reduction of drug cost 38 (41.3) 
Availability of essential drugs 27(29.3) 
Enforcement of drug policies 27(29.3) 
Discourage multiple prescription(polypharmacy) 20 (22.2) 
Eliminating corruption 20 (22.2) 
Reduction of stock-out 17 (18.5) 
Effective transportation and distribution 17 (18.5) 
Reduce wastage of drugs 17 (18.5) 
Staff training on Inventory management 13(14.1) 
Enhancing public education on drug use 13 (14.1) 
Improve storage facility 13(14.1) 
Making pharmacists in charge of distribution and sales of drugs 7 (7.4) 
Eliminating bottle necks 1 (1.1) 
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3.5 Available and accessible WHO indicator drugs in health facilities within Calabar 
Drug availability: Public Facilities  
Table 17a. Percentage availability of WHO indicator drugs in health facilities 
 OB GB 
1 Salbutamol inhaler 0.1mg dose 40.0 40.0 
2  Glibenclamide 5mg tablets 40.0 100 
3  Atenolol  50mg tablets 0.00 68.5 
4 Captopril 25mg tablets 0.00 71.4 
5  Simvastatin 20mg tabs 0.00 66.7 
6  Amitriptyline 25mg tabs 0.00 100.0 
7  Ciprofloxacin 500mg tabs 40.0 100.0 
8  Co-trimoxazole 80 + 240mg Susp 0.00 100.0 
9  Amoxicillin 500mg capsules 20.0 100.0 
10  Ceftriaxone 1g injection 40.0 83.3 
11  Diazepam 5mg tabs 20.0 66.7 
12  Diclofenac 50mg tablets 40.0 100.0 
13  Paracetamol syrup 20.0 100.0 
14  Omeprazole  20mg tablets 20.0 100.0 
15   Albendazole 200mg tablets 40.0 100.0 
16   Metronidazole 200mg tabs 20.0 100.0 
17   Insulin injection 0.00 N/A 
18   ORT N/A 100.0 
19  Artemether/lumefantrine tabs 20.0 100.0 
20  Oxytocin injection 0.00 33.3 
21  Magnesium sulphate injection 0.00 6.25 
Overall availability (%) 16.19 44.76 
Drug availability: Private Facilities 
Table17 b. Percentage availability of WHO indicator drugs in health facilities 
 OB GB 
1 Salbutamol inhaler 0.1mg dose 100.0 71.4 
2  Glibenclamide 5mg tablets 100.0 100 
3  Atenolol  50mg tablets 57.1 85.7 
4 Captopril 25mg tablets 28.6  71.4 
5  Simvastatin 20mg tabs 42.8 71.4 
6  Amitriptyline 25mg tabs 14.3 57.1 
7  Ciprofloxacin 500mg tabs 100.0 100.0 
8  Co-trimoxazole 80 + 240mg Susp 85.7 100.0 
9  Amoxicillin 500mg capsules 100.0 100.0 
10  Ceftriaxone 1g injection 100.0 100.0 
11  Diazepam 5mg tabs 85.7 71.4 
12  Diclofenac 50mg tablets 100.0 100.0 
13  Paracetamol Syrup 42.3 100.0 
14  Omeprazole 20mg tablets 14.3 100.0 
15   Albendazole 200mg tablets 100.0 100.0 
16   Metronidazole 200mg tablets 71.4 100.0 
17   Insulin injection 85.7 N/A 
18   ORT N/A 100.0 
19  Artemether/lumefantrine tablets 100.0 100.0 
20  Oxytocin injection 14.2 28.5 
21  Magnesium sulphate injection N/A 28.5 
Overall availability (%) 64.76 82.3 
 
4. Discussion 
This study shows that the majority of the respondents were males (66.3%)and more also in the private sector 
than in the public sectors .The reason being that more males are adapted to the pharmaceutical environment 
while more females were in the hospital sector (28.2%) than in the community practice.51.1% of the  
respondents were between the ages of 31-40 is the more productive ages of the work force .Majority of the 
respondents(89.2%) had Bachelor of Pharmacy as the highest qualification  and the scenario is not acceptable as 
higher qualifications leads to higher quality of care. Pharmacist s role in the health setting is evolving and they 
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need to be trained to meet this demand. 
Characteristics of health facility showed that 34.8%were in the private sector while 65.2% of the 
respondents involved in public drug outlets showing that they had first-hand experience of the situation.100% of 
the facilities had alternative power supply indicating that the storage of drugs was at a favourable temperature 
and quality  assured. 84.4% sourced their drugs directly from drug manufacturing companies ensures that 
counterfeit medicines are not purchased and also ensures quality. 
A research by Irene et al. (2016) highlighted the following as barriers to availability and accessibility of 
essential drugs: lack of availability due to poor funding, poor and inefficient delivery and supply system, 
irrational prescription and prescription outside the essential drug list. In this research,  One of the super 
suggestions proffered by the respondents on how to improve on accessibility and availability of essential drugs 
in Calabar metropolis in particular and Cross River State in general is to improve funding of essential drugs to 
enable more drugs to be purchased as seen in the response of 55(59.8%) of the respondents. Also, about 37 
(40.2%) of the respondents were of the opinion that drug suppliers should be paid on time to enable them extend 
credit facilities and also the cost of drugs should be reduced to make the drugs more affordable. 
To make drugs easily available, 27(29.3%) respondents called for the enforcement of relevant drug 
policies, avoid corruption which meant diversion of monies that should be used to purchase essential drugs for 
the populace and multiple prescriptions should be discouraged. About 20% of the respondents were of the 
opinion that there should be effective transportation and distribution of drug products so that stock outs will be 
avoided when the drugs are taken to places where they will be effectively utilized. Also the incidences of expired 
drugs will be minimized with less wastage. 
More so, about 15% of the respondent believed that health personnel should be trained in inventory 
management of drugs and public education on drug use should be enhanced. In addition, storage facilities of 
drugs should be improved and finally about 7% of the respondents believed that making pharmacists in charge of 
distribution and sales of drug will improve accessibility and availability. 
Furthermore, the research shows 16.19 % and 44.76 %; OB and GB overall drug availability in the 
public health facilities respectively and 64.76 % and 82.3 0 %, OB and GB overall drug availability in the 
private health facilities indicating a higher drug availability in the private facilities. In facilities, Salbutamol 
inhaler 0.1mg dose and Glibenclamide 5mg tablets are the most readily accessible and available drugs. 
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